{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:28:48Z","timestamp":1790494128170,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea","award":["315044031SB010"],"award-info":[{"award-number":["315044031SB010"]}]},{"name":"Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea","award":["316043-3"],"award-info":[{"award-number":["316043-3"]}]},{"name":"Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea","award":["110057-03"],"award-info":[{"award-number":["110057-03"]}]},{"name":"Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea","award":["111106-02"],"award-info":[{"award-number":["111106-02"]}]},{"name":"Internal Research Fund of Animal Quarantine and Inspection Agency (QIA)","award":["2012-0619"],"award-info":[{"award-number":["2012-0619"]}]},{"name":"Internal Research Fund of Animal Quarantine and Inspection Agency (QIA)","award":["2013-1181"],"award-info":[{"award-number":["2013-1181"]}]},{"DOI":"10.13039\/501100002462","name":"Chungnam National University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002462","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Microbiology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.vetmic.2017.01.020","type":"journal-article","created":{"date-parts":[[2017,1,21]],"date-time":"2017-01-21T17:48:03Z","timestamp":1485020883000},"page":"240-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Mucosal vaccination of conserved sM2, HA2 and cholera toxin subunit A1 (CTA1) fusion protein with poly gamma-glutamate\/chitosan nanoparticles (PC NPs) induces protection against divergent influenza subtypes"],"prefix":"10.1016","volume":"201","author":[{"given":"Mohammed Y.E.","family":"Chowdhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Bashir","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.Y.","family":"Hewawaduge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zannatul","family":"Ferdowshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon-Hee","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul-Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vetmic.2017.01.020_bib0005","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/mabi.200500036","article-title":"In vitro enzymatic degradation of nanoparticles prepared from hydrophobically-modified poly(gamma-glutamic acid)","volume":"5","author":"Akagi","year":"2005","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0010","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1128\/IAI.68.10.5764-5770.2000","article-title":"Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens","volume":"68","author":"Bacon","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0015","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.addr.2009.11.012","article-title":"Nanotechnology solutions for mucosal immunization","volume":"62","author":"Chadwick","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0020","doi-asserted-by":"crossref","first-page":"e94051","DOI":"10.1371\/journal.pone.0094051","article-title":"Mucosal vaccination with recombinant Lactobacillus casei-displayed CTA1-conjugated consensus matrix protein-2 (sM2) induces broad protection against divergent influenza subtypes in BALB\/c mice","volume":"9","author":"Chowdhury","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vetmic.2017.01.020_bib0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1743-422X-11-21","article-title":"Heterosubtypic protective immunity against widely divergent influenza subtypes induced by fusion protein 4sM2 in BALB\/c mice","volume":"11","author":"Chowdhury","year":"2014","journal-title":"Virol. J."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0030","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.addr.2008.09.005","article-title":"Nanoparticles for nasal vaccination","volume":"61","author":"Csaba","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0035","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.vaccine.2007.12.027","article-title":"CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine","volume":"26","author":"Eliasson","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vetmic.2017.01.020_bib0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.virusres.2004.02.030","article-title":"A universal human influenza A vaccine","volume":"103","author":"Fiers","year":"2004","journal-title":"Virus Res."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0045","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0264-410X(03)00071-9","article-title":"The annual production cycle for influenza vaccine","volume":"21","author":"Gerdil","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vetmic.2017.01.020_bib0050","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1099\/vir.0.83524-0","article-title":"Antibodies induced by the HA2 glycopolypeptide of influenza virus haemagglutinin improve recovery from influenza A virus infection","volume":"89","author":"Gocnik","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0055","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/j.vaccine.2003.11.011","article-title":"Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1","volume":"22","author":"Gogev","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vetmic.2017.01.020_bib0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.vaccine.2007.10.062","article-title":"Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin","volume":"26","author":"Huleatt","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vetmic.2017.01.020_bib0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/jps.20493","article-title":"Pharmaceutical and immunological evaluation of human papillomavirus viruslike particle as an antigen carrier","volume":"95","author":"Ionescu","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0070","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0264-410X(98)00077-2","article-title":"Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice","volume":"16","author":"Jabbal-Gill","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vetmic.2017.01.020_bib0075","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.4049\/jimmunol.172.9.5598","article-title":"Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity","volume":"172","author":"Jegerlehner","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.virusres.2011.09.037","article-title":"Novel vaccines against influenza viruses","volume":"162","author":"Kang","year":"2011","journal-title":"Virus Res."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0085","doi-asserted-by":"crossref","first-page":"775","DOI":"10.4049\/jimmunol.179.2.775","article-title":"Oral administration of high molecular mass poly-gamma-glutamate induces NK cell-mediated antitumor immunity","volume":"179","author":"Kim","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0090","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1743-422X-10-104","article-title":"Prokaryote-expressed M2e protein improves H9N2 influenza vaccine efficacy and protection against lethal influenza A virus in mice","volume":"10","author":"Kim","year":"2013","journal-title":"Virol. J."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0095","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1073\/pnas.79.15.4800","article-title":"Evolution of influenza A and B viruses: conservation of structural features in the hemagglutinin genes","volume":"79","author":"Krystal","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0100","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1056\/NEJMra1002842","article-title":"CURRENT CONCEPTS influenza vaccines for the future","volume":"363","author":"Lambert","year":"2010","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0105","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.coi.2011.03.009","article-title":"Defending the mucosa: adjuvant and carrier formulations for mucosal immunity","volume":"23","author":"Lawson","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0110","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s00262-009-0689-4","article-title":"Oral administration of poly-gamma-glutamate induces TLR4- and dendritic cell-dependent antitumor effect","volume":"58","author":"Lee","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0115","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jviromet.2013.08.022","article-title":"The highly conserved HA2 protein of the influenza a virus induces a cross protective immune response","volume":"194","author":"Lee","year":"2013","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.vetmic.2017.01.020_bib0120","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7774\/cevr.2014.3.1.12","article-title":"New vaccines against influenza virus","volume":"3","author":"Lee","year":"2014","journal-title":"Clin. Exp. Vaccine Res."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0125","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1021\/bm049312a","article-title":"Preparation of nanoparticles composed of chitosan\/poly-gamma-glutamic acid and evaluation of their permeability through Caco-2 cells","volume":"6","author":"Lin","year":"2005","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.vetmic.2017.01.020_bib0130","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1021\/bm0607776","article-title":"Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery","volume":"8","author":"Lin","year":"2007","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.vetmic.2017.01.020_bib0135","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.micinf.2004.10.006","article-title":"Sequence comparison between the extracellular domain of M2 protein human and avian influenza A virus provides new information for bivalent influenza vaccine design","volume":"7","author":"Liu","year":"2005","journal-title":"Microbes Infect.Inst. Pasteur"},{"key":"10.1016\/j.vetmic.2017.01.020_bib0140","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.vetmic.2012.05.035","article-title":"Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate\/chitosan nanoparticles induces protection against highly pathogenic influenza A virus","volume":"160","author":"Moon","year":"2012","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0145","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1086\/589885","article-title":"Prevention of symptomatic seasonal influenza in 2005\u20132006 by inactivated and live attenuated vaccines","volume":"198","author":"Ohmit","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0150","doi-asserted-by":"crossref","first-page":"8270","DOI":"10.1016\/j.vaccine.2007.09.051","article-title":"Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity","volume":"25","author":"Okamoto","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vetmic.2017.01.020_bib0155","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.1016\/j.vaccine.2009.07.037","article-title":"Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice","volume":"27","author":"Okamoto","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vetmic.2017.01.020_bib0160","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1211\/0022357021778448","article-title":"Recent trends in stabilizing protein structure upon encapsulation and release from bioerodible polymers","volume":"54","author":"Perez","year":"2002","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0165","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev-med-120611-145115","article-title":"Toward a universal influenza virus vaccine: prospects and challenges","volume":"64","author":"Pica","year":"2013","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0170","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/cbdv.200900283","article-title":"New biological functions and applications of high-molecular-mass poly-gamma-glutamic acid","volume":"7","author":"Poo","year":"2010","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0175","doi-asserted-by":"crossref","first-page":"e13162","DOI":"10.1371\/journal.pone.0013162","article-title":"Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses","volume":"5","author":"Price","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.vetmic.2017.01.020_bib0180","doi-asserted-by":"crossref","first-page":"e9161","DOI":"10.1371\/journal.pone.0009161","article-title":"Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice","volume":"5","author":"Quan","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.vetmic.2017.01.020_bib0185","doi-asserted-by":"crossref","first-page":"e27953","DOI":"10.1371\/journal.pone.0027953","article-title":"Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza","volume":"6","author":"Shim","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vetmic.2017.01.020_bib0190","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.virol.2010.05.034","article-title":"Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles","volume":"405","author":"Song","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.vetmic.2017.01.020_bib0195","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.antiviral.2012.09.008","article-title":"Heterosubtypic protection against influenza A induced by adenylate cyclase toxoids delivering conserved HA2 subunit of hemagglutinin","volume":"97","author":"Stanekova","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0200","doi-asserted-by":"crossref","first-page":"7690","DOI":"10.1016\/j.vaccine.2010.09.019","article-title":"Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant","volume":"28","author":"Sui","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vetmic.2017.01.020_bib0205","doi-asserted-by":"crossref","first-page":"8682","DOI":"10.1073\/pnas.0402630101","article-title":"Protection against lethal influenza virus challenge by RNA interference in vivo","volume":"101","author":"Tompkins","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0210","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3201\/eid1303.061125","article-title":"Matrix protein 2 vaccination and protection against influenza viruses: including subtype H5N1","volume":"13","author":"Tompkins","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0215","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1128\/JVI.64.3.1375-1377.1990","article-title":"Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice","volume":"64","author":"Treanor","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0220","doi-asserted-by":"crossref","first-page":"18979","DOI":"10.1073\/pnas.1013387107","article-title":"Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes","volume":"107","author":"Wang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0225","doi-asserted-by":"crossref","first-page":"e1000796","DOI":"10.1371\/journal.ppat.1000796","article-title":"Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins","volume":"6","author":"Wang","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0230","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/MMBR.56.1.152-179.1992","article-title":"Evolution and ecology of influenza A viruses","volume":"56","author":"Webster","year":"1992","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.vetmic.2017.01.020_bib0235","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0264-410X(01)00423-6","article-title":"ProJuvant (Pluronic F127\/chitosan) enhances the immune response to intranasally administered tetanus toxoid","volume":"20","author":"Westerink","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vetmic.2017.01.020_bib0240","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1016\/j.vaccine.2009.04.075","article-title":"The co-administration of CpG-ODN influenced protective activity of influenza M2e vaccine","volume":"27","author":"Wu","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vetmic.2017.01.020_bib0245","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1093\/abbs\/gmp098","article-title":"Modeling of protein refolding from inclusion bodies","volume":"41","author":"Zhang","year":"2009","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"}],"container-title":["Veterinary Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378113516305223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378113516305223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T10:15:09Z","timestamp":1601374509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378113516305223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":49,"alternative-id":["S0378113516305223"],"URL":"https:\/\/doi.org\/10.1016\/j.vetmic.2017.01.020","relation":{},"ISSN":["0378-1135"],"issn-type":[{"value":"0378-1135","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucosal vaccination of conserved sM2, HA2 and cholera toxin subunit A1 (CTA1) fusion protein with poly gamma-glutamate\/chitosan nanoparticles (PC NPs) induces protection against divergent influenza subtypes","name":"articletitle","label":"Article Title"},{"value":"Veterinary Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vetmic.2017.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}